Breaking News Instant updates and real-time market news.

KHTRF

Knight Therapeutics

$4.19 /

-0.26 (-5.84%)

07:42
03/24/22
03/24
07:42
03/24/22
07:42

Knight Therapeutics reports Q4 EPS (C$0.07) vs. C$0.6 last year

Reports Q4 revenue C$58.27M vs. C$55.19M last year. "I am excited to announce that 2021 was a record-setting year in Knight's history, despite the ongoing challenges posed by the pandemic. During the year, we made significant strides towards completing the integration of the Grupo Biotoscana acquisition, all while strengthening the team and processes and driving strong performance. As part of our integration activities, we completed the implementation of several key systems including, a global CRM, HR IS and a global pharmacovigilance system. In addition, we implemented ERP for 14 legal entities in 6 countries. We further strengthened Knight's management team with the addition of a Global VP Commercial, a Global VP Scientific Affairs, a Global VP Legal and Compliance and a Global VP Human Resources and most recently added a VP Manufacturing and Operations, to continue delivering on growth and operational excellence. Our business development team closed the acquisition of Exelon and entered into an exclusive supply and distribution agreement with Incyte. Our regulatory team advanced our portfolio with the approval of Halaven, Lenvima and Rembre in Colombia as well as the approval of Nerlynx, while our commercial team continued to deliver on strong growth of our key brands. It is thanks to the hard work of our employees that we achieved unprecedented results in 2021 and we are entering 2022 with a stronger platform that is well equipped to continue delivering on further growth and success." said Samira Sakhia, President and CEO.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Vuzix reports follow-on smart glasses order valued at over $350,000 » 08:23
07/06/22
07/06
08:23
07/06/22
08:23
VUZI

Vuzix

$7.33 /

+0.63 (+9.40%)

Yesterday, Vuzix…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VUZI Vuzix
$7.33 /

+0.63 (+9.40%)

VUZI Vuzix
$7.33 /

+0.63 (+9.40%)

03/02/22 Craig-Hallum
Vuzix price target lowered to $11 from $30 at Craig-Hallum
12/21/21 Dawson James
Vuzix initiated with a Buy at Dawson James
VUZI Vuzix
$7.33 /

+0.63 (+9.40%)

VUZI Vuzix
$7.33 /

+0.63 (+9.40%)

VUZI Vuzix
$7.33 /

+0.63 (+9.40%)

Hot Stocks
Norwegian Cruise Line to no longer require pre-cruise COVID-19 testing » 08:22
07/06/22
07/06
08:22
07/06/22
08:22
NCLH

Norwegian Cruise Line

$12.47 /

+1.13 (+9.96%)

Norwegian Cruise Line…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NCLH Norwegian Cruise Line
$12.47 /

+1.13 (+9.96%)

NCLH Norwegian Cruise Line
$12.47 /

+1.13 (+9.96%)

06/29/22 Barclays
Barclays initiates cruise line space with Royal Caribbean top pick
06/28/22 Barclays
Norwegian Cruise Line initiated with an Equal Weight at Barclays
06/21/22 Deutsche Bank
Norwegian Cruise Line price target lowered to $17 from $23 at Deutsche Bank
06/09/22 Susquehanna
Norwegian Cruise Line initiated with a Positive at Susquehanna
NCLH Norwegian Cruise Line
$12.47 /

+1.13 (+9.96%)

NCLH Norwegian Cruise Line
$12.47 /

+1.13 (+9.96%)

NCLH Norwegian Cruise Line
$12.47 /

+1.13 (+9.96%)

NCLH Norwegian Cruise Line
$12.47 /

+1.13 (+9.96%)

Hot Stocks
Sarepta's Duchenne muscular dystrophy candidate shows efficacy in studies » 08:22
07/06/22
07/06
08:22
07/06/22
08:22
SRPT

Sarepta

$75.70 /

+0.01 (+0.01%)

, RHHBY

Roche

$41.57 /

-0.44 (-1.05%)

Sarepta (SRPT) and its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRPT Sarepta
$75.70 /

+0.01 (+0.01%)

RHHBY Roche
$41.57 /

-0.44 (-1.05%)

SRPT Sarepta
$75.70 /

+0.01 (+0.01%)

07/05/22 Morgan Stanley
Sarepta named a 'Catalyst Driven Idea' at Morgan Stanley ahead of 9001 update
06/24/22 Evercore ISI
Sarepta clinical hold has 'no impact' on Evercore ISI's model
06/24/22 Cantor Fitzgerald
Sarepta price target lowered to $128 from $140 at Cantor Fitzgerald
06/24/22 Credit Suisse
Sarepta price target lowered to $90 from $95 at Credit Suisse
RHHBY Roche
$41.57 /

-0.44 (-1.05%)

06/27/22 Cowen
Roche price target lowered to $48 from $58 at Cowen
06/02/22 Piper Sandler
Piper ups Repare Therapeutics target after 'great deal' with Roche
05/19/22 Credit Suisse
Roche price target lowered to CHF 350 from CHF 370 at Credit Suisse
05/13/22 Jefferies
Roche downgraded to Hold from Buy at Jefferies
SRPT Sarepta
$75.70 /

+0.01 (+0.01%)

RHHBY Roche
$41.57 /

-0.44 (-1.05%)

  • 14
    Oct
RHHBY Roche
$41.57 /

-0.44 (-1.05%)

SRPT Sarepta
$75.70 /

+0.01 (+0.01%)

RHHBY Roche
$41.57 /

-0.44 (-1.05%)

Hot Stocks
Jack Henry announces collaboration with LINKBANCORP » 08:22
07/06/22
07/06
08:22
07/06/22
08:22
JKHY

Jack Henry

$183.66 /

-0.76 (-0.41%)

Jack Henry &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JKHY Jack Henry
$183.66 /

-0.76 (-0.41%)

JKHY Jack Henry
$183.66 /

-0.76 (-0.41%)

06/15/22 Morgan Stanley
Jack Henry initiated with an Equal Weight at Morgan Stanley
03/01/22 Oppenheimer
Jack Henry upgraded to Outperform from Perform at Oppenheimer
02/11/22 DA Davidson
Jack Henry price target raised to $204 from $188 at DA Davidson
02/10/22 DA Davidson
Jack Henry price target raised to $204 from $188 at DA Davidson
JKHY Jack Henry
$183.66 /

-0.76 (-0.41%)

JKHY Jack Henry
$183.66 /

-0.76 (-0.41%)

JKHY Jack Henry
$183.66 /

-0.76 (-0.41%)

Hot Stocks
DoorDash, Uber slide after Amazon strikes deal with Grubhub » 08:22
07/06/22
07/06
08:22
07/06/22
08:22
DASH

DoorDash

$74.90 /

+7.07 (+10.42%)

, UBER

Uber

$22.53 /

+1.18 (+5.53%)

, AMZN

Amazon.com

$113.56 /

+3.995 (+3.65%)

, TKAYY

Just Eat Takeaway.com

$10.47 /

+ (+0.00%)

Shares of DoorDash (DASH)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DASH DoorDash
$74.90 /

+7.07 (+10.42%)

UBER Uber
$22.53 /

+1.18 (+5.53%)

AMZN Amazon.com
$113.56 /

+3.995 (+3.65%)

TKAYY Just Eat Takeaway.com
$10.47 /

+ (+0.00%)

DASH DoorDash
$74.90 /

+7.07 (+10.42%)

06/29/22 JPMorgan
DoorDash price target lowered to $90 from $100 at JPMorgan
06/27/22 Needham
DoorDash price target lowered to $100 from $140 at Needham
06/21/22 Goldman Sachs
DoorDash reinstated with a Neutral at Goldman Sachs
06/06/22 Raymond James
DoorDash initiated with a Market Perform at Raymond James
UBER Uber
$22.53 /

+1.18 (+5.53%)

06/29/22 JPMorgan
Uber price target lowered to $48 from $60 at JPMorgan
06/29/22 Wedbush
Uber assumed with an Outperform at Wedbush
06/24/22 Wolfe Research
Uber price target lowered to $27 from $30 at Wolfe Research
06/16/22 Mizuho
Uber hits 'speed bump' in Massachusetts, says Mizuho
AMZN Amazon.com
$113.56 /

+3.995 (+3.65%)

06/29/22 JPMorgan
Amazon.com price target lowered to $175 from $200 at JPMorgan
06/29/22 Redburn
Microsoft initiated with a Buy at Redburn
06/29/22 Redburn
Amazon.com initiated with a Buy at Redburn
06/29/22 Wolfe Research
Amazon.com price target lowered to $140 from $145 at Wolfe Research
TKAYY Just Eat Takeaway.com
$10.47 /

+ (+0.00%)

07/07/21 Bernstein
Just Eat Takeaway.com initiated with an Outperform at Bernstein
DASH DoorDash
$74.90 /

+7.07 (+10.42%)

UBER Uber
$22.53 /

+1.18 (+5.53%)

AMZN Amazon.com
$113.56 /

+3.995 (+3.65%)

  • 19
    Aug
  • 29
    Jul
DASH DoorDash
$74.90 /

+7.07 (+10.42%)

UBER Uber
$22.53 /

+1.18 (+5.53%)

AMZN Amazon.com
$113.56 /

+3.995 (+3.65%)

DASH DoorDash
$74.90 /

+7.07 (+10.42%)

UBER Uber
$22.53 /

+1.18 (+5.53%)

AMZN Amazon.com
$113.56 /

+3.995 (+3.65%)

DASH DoorDash
$74.90 /

+7.07 (+10.42%)

UBER Uber
$22.53 /

+1.18 (+5.53%)

AMZN Amazon.com
$113.56 /

+3.995 (+3.65%)

Hot Stocks
IBM announces it acquired Databand.ai » 08:21
07/06/22
07/06
08:21
07/06/22
08:21
IBM

IBM

$137.63 /

-3.505 (-2.48%)

IBM announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IBM IBM
$137.63 /

-3.505 (-2.48%)

IBM IBM
$137.63 /

-3.505 (-2.48%)

06/27/22 Northland
Telos price target raised to $11 at Northland after Xacta checks
05/18/22 Jefferies
Information Technology sector upgraded to Bullish at Jefferies
04/20/22 BMO Capital
IBM price target raised to $152 from $148 at BMO Capital
04/20/22 BofA
IBM price target raised to $165 from $162 at BofA
IBM IBM
$137.63 /

-3.505 (-2.48%)

IBM IBM
$137.63 /

-3.505 (-2.48%)

IBM IBM
$137.63 /

-3.505 (-2.48%)

IBM IBM
$137.63 /

-3.505 (-2.48%)

Earnings
Rail Vision reports Q1 EPS (26c) vs. (32c) last year » 08:21
07/06/22
07/06
08:21
07/06/22
08:21
RVSN

Rail Vision

/

+

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RVSN Rail Vision
/

+

RVSN Rail Vision
/

+

05/02/22 Aegis
Rail Vision initiated with a Buy at Aegis
RVSN Rail Vision
/

+

Hot Stocks
Immutep granted Japanese patent for IMP761 » 08:19
07/06/22
07/06
08:19
07/06/22
08:19
IMMP

Immutep

$2.16 /

+0.125 (+6.16%)

Immutep is pleased to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMMP Immutep
$2.16 /

+0.125 (+6.16%)

IMMP Immutep
$2.16 /

+0.125 (+6.16%)

12/02/21 Jefferies
Immutep initiated with a Buy at Jefferies
08/03/21 Ladenburg
Ladenburg starts Immutep with Buy into 'value-driving' events
08/03/21 Ladenburg
Immutep initiated with a Buy at Ladenburg
07/16/21 Maxim
Immutep assumed with a Buy at Maxim
Hot Stocks
Ovintiv to sell portions of its Uinta, Bakken assets for $250M » 08:19
07/06/22
07/06
08:19
07/06/22
08:19
OVV

Ovintiv

$39.91 /

-3.58 (-8.23%)

Ovintiv announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OVV Ovintiv
$39.91 /

-3.58 (-8.23%)

OVV Ovintiv
$39.91 /

-3.58 (-8.23%)

06/28/22 JPMorgan
Ovintiv upgraded to Overweight from Neutral at JPMorgan
06/16/22 National Bank
Ovintiv price target raised to $115 from $90 at National Bank
06/14/22 Barclays
Ovintiv price target raised to $72 from $56 at Barclays
05/31/22 Mizuho
Ovintiv price target lowered to $77 from $78 at Mizuho
OVV Ovintiv
$39.91 /

-3.58 (-8.23%)

OVV Ovintiv
$39.91 /

-3.58 (-8.23%)

OVV Ovintiv
$39.91 /

-3.58 (-8.23%)

OVV Ovintiv
$39.91 /

-3.58 (-8.23%)

Hot Stocks
Poet announces sampling of 200G FR4 Transmit, Receive Optical Engines » 08:18
07/06/22
07/06
08:18
07/06/22
08:18
POETF

Poet Technologies

/

+

POET Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
POETF Poet Technologies
/

+

Hot Stocks
NextDecade executes 20-year SPA with Guangdong Energy » 08:17
07/06/22
07/06
08:17
07/06/22
08:17
NEXT

NextDecade

$4.62 /

+0.205 (+4.65%)

NextDecade announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEXT NextDecade
$4.62 /

+0.205 (+4.65%)

NEXT NextDecade
$4.62 /

+0.205 (+4.65%)

05/02/22 Stifel
Stifel ticks up NextDecade target but still sees 'substantial risk'
04/26/22 Stifel
NextDecade downgraded to Sell from Hold at Stifel
04/01/22 Credit Suisse
NextDecade downgraded to Neutral from Outperform at Credit Suisse
NEXT NextDecade
$4.62 /

+0.205 (+4.65%)

Hot Stocks
Cerberus Cyber completes acquisition of CyberViking » 08:17
07/06/22
07/06
08:17
07/06/22
08:17
CISO

Cerberus Cyber

$3.75 /

+0.1 (+2.74%)

Cerberus Cyber has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CISO Cerberus Cyber
$3.75 /

+0.1 (+2.74%)

  • 14
    Jan
CISO Cerberus Cyber
$3.75 /

+0.1 (+2.74%)

Recommendations
GreenPower Motor price target lowered to $9 from $14 at Maxim » 08:16
07/06/22
07/06
08:16
07/06/22
08:16
GP

GreenPower Motor

$3.44 /

+0.29 (+9.21%)

Maxim analyst Tate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GP GreenPower Motor
$3.44 /

+0.29 (+9.21%)

GP GreenPower Motor
$3.44 /

+0.29 (+9.21%)

03/02/22 Roth Capital
Roth upgrades Workhorse Group to Buy after 'substantial operating progress'
02/15/22 Roth Capital
Roth Capital upgrades GreenPower Motor to Buy with $13 price target
02/15/22 Roth Capital
GreenPower Motor upgraded to Buy from Neutral at Roth Capital
02/10/22 Maxim
GreenPower Motor price target lowered to $14 from $22 at Maxim
GP GreenPower Motor
$3.44 /

+0.29 (+9.21%)

GP GreenPower Motor
$3.44 /

+0.29 (+9.21%)

Hot Stocks
Dynatronics: CEO Krier to resume CFO role, Mike Withers joins as CIO » 08:16
07/06/22
07/06
08:16
07/06/22
08:16
DYNT

Dynatronics

/

+

Dynatronics Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DYNT Dynatronics
/

+

DYNT Dynatronics
/

+

Hot Stocks
NextCure reports publication supporting development of cancer candidate NC318 » 08:16
07/06/22
07/06
08:16
07/06/22
08:16
NXTC

NextCure

$4.62 /

+0.115 (+2.55%)

NextCure announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NXTC NextCure
$4.62 /

+0.115 (+2.55%)

NXTC NextCure
$4.62 /

+0.115 (+2.55%)

05/23/22 Piper Sandler
NextCure price target lowered to $13 from $21 at Piper Sandler
03/01/22 Ladenburg
NextCure initiated with Buy, $16 price target at Ladenburg
03/01/22 Ladenburg
NextCure initiated with a Buy at Ladenburg
11/05/21 Piper Sandler
NextCure's Phase II NC318 study continuing weekly dosing, says Piper Sandler
Hot Stocks
Bebuzee to file RegA next week » 08:16
07/06/22
07/06
08:16
07/06/22
08:16
ENGA

Engage Technologies, Inc.

/

+

The executive management…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENGA Engage Technologies, Inc.
/

+

Hot Stocks
Coherus, Junshi announces FDA acceptance of resubmission of Toripalimab BLA » 08:15
07/06/22
07/06
08:15
07/06/22
08:15
CHRS

Coherus Biosciences

$8.55 /

+0.72 (+9.20%)

Shanghai Junshi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHRS Coherus Biosciences
$8.55 /

+0.72 (+9.20%)

CHRS Coherus Biosciences
$8.55 /

+0.72 (+9.20%)

06/13/22 UBS
Coherus Biosciences initiated with a Neutral at UBS
06/13/22 UBS
Coherus Biosciences initiated with a Neutral at UBS
05/20/22 Mizuho
Coherus Biosciences price target lowered to $25 from $30 at Mizuho
05/09/22 Barclays
Coherus Biosciences price target lowered to $15 from $20 at Barclays
CHRS Coherus Biosciences
$8.55 /

+0.72 (+9.20%)

Downgrade
Evolution Petroleum downgraded to Neutral from Buy at Roth Capital » 08:15
07/06/22
07/06
08:15
07/06/22
08:15
EPM

Evolution Petroleum

$5.05 /

-0.45 (-8.18%)

Roth Capital analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EPM Evolution Petroleum
$5.05 /

-0.45 (-8.18%)

Initiation
Aclarion initiated with a Buy at Maxim » 08:14
07/06/22
07/06
08:14
07/06/22
08:14
ACON

Aclarion

/

+

Maxim analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACON Aclarion
/

+

ACON Aclarion
/

+

07:42 Today Maxim
Aclarion initiated with a Buy at Maxim
  • 22
    Apr
Hot Stocks
Farmmi announces new international order » 08:14
07/06/22
07/06
08:14
07/06/22
08:14
FAMI

Farmmi

$1.08 /

+0.015 (+1.42%)

Farmmi announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FAMI Farmmi
$1.08 /

+0.015 (+1.42%)

Hot Stocks
Spire Marketing to provide RSG through agreement with Ascent Resources » 08:13
07/06/22
07/06
08:13
07/06/22
08:13
SR

Spire

$72.33 /

-3.94 (-5.17%)

Spire Marketing has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SR Spire
$72.33 /

-3.94 (-5.17%)

SR Spire
$72.33 /

-3.94 (-5.17%)

05/25/22 Mizuho
Spire price target raised to $77 from $74 at Mizuho
04/29/22 Mizuho
Spire price target raised to $74 from $68 at Mizuho
04/19/22 Wells Fargo
Spire price target raised to $81 from $70 at Wells Fargo
04/18/22 BofA
Spire upgraded to Neutral from Underperform at BofA
SR Spire
$72.33 /

-3.94 (-5.17%)

Hot Stocks
Eyenovia partner enrolls first patient in Phase 3 trial of presbyopia candidate » 08:12
07/06/22
07/06
08:12
07/06/22
08:12
EYEN

Eyenovia

$1.85 /

-0.06 (-3.14%)

Eyenovia's strategic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYEN Eyenovia
$1.85 /

-0.06 (-3.14%)

EYEN Eyenovia
$1.85 /

-0.06 (-3.14%)

10/26/21 Northland
Eyenovia price target lowered to $9 from $12 at Northland
EYEN Eyenovia
$1.85 /

-0.06 (-3.14%)

Downgrade
Alexco Resource downgraded to Neutral from Buy at Roth Capital » 08:12
07/06/22
07/06
08:12
07/06/22
08:12
AXU

Alexco Resource

/

+

Roth Capital analyst Joe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXU Alexco Resource
/

+

AXU Alexco Resource
/

+

07:03 Today Alliance Global Partners
Alexco Resource downgraded to Neutral from Buy at Alliance Global Partners
06/22/22 Cantor Fitzgerald
Alexco Resource downgraded to Speculative Buy from Buy at Cantor Fitzgerald
06/22/22 Alliance Global Partners
Alexco Resource price target lowered to $1.75 from $3.25 at Alliance Global Partners
10/29/21 Canaccord
Alexco Resource upgraded to Speculative Buy from Hold at Canaccord
AXU Alexco Resource
/

+

AXU Alexco Resource
/

+

Hot Stocks
Catalyst Biosciences says court denies JDS1's motion for expedited proceedings » 08:12
07/06/22
07/06
08:12
07/06/22
08:12
CBIO

Catalyst Biosciences

$1.77 /

-0.015 (-0.84%)

Catalyst Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CBIO Catalyst Biosciences
$1.77 /

-0.015 (-0.84%)

CBIO Catalyst Biosciences
$1.77 /

-0.015 (-0.84%)

05/23/22 Piper Sandler
Piper Sandler remains bullish on Catalyst after sale of complement portfolio
03/31/22 Piper Sandler
Piper says 'stick it out' with Catalyst Biosciences exploring options
11/12/21 JonesTrading
Catalyst Biosciences downgraded to Hold from Buy at JonesTrading
11/12/21 Piper Sandler
Catalyst Biosciences price target lowered to $4 from $16 at Piper Sandler
CBIO Catalyst Biosciences
$1.77 /

-0.015 (-0.84%)

CBIO Catalyst Biosciences
$1.77 /

-0.015 (-0.84%)

CBIO Catalyst Biosciences
$1.77 /

-0.015 (-0.84%)

Periodicals
Kuo: Apple's A16 processor to be exclusive to iPhone 14 Pro, AppleInsider says » 08:11
07/06/22
07/06
08:11
07/06/22
08:11
AAPL

Apple

$141.60 /

+2.785 (+2.01%)

Apple is expected to make…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$141.60 /

+2.785 (+2.01%)

AAPL Apple
$141.60 /

+2.785 (+2.01%)

07/05/22 Morgan Stanley
Apple App Store revenue grew 5% in June quarter, says Morgan Stanley
07/01/22 JPMorgan
Apple near-term estimates 'resilient' despite concerns, says JPMorgan
06/30/22 Tigress Financial
Tigress Financial reiterates Strong Buy on Apple, sees further upside in shares
06/30/22 Morgan Stanley
Morgan Stanley Asia checks 'mostly validate' Qualcomm-Apple baseband chatter
AAPL Apple
$141.60 /

+2.785 (+2.01%)

AAPL Apple
$141.60 /

+2.785 (+2.01%)

AAPL Apple
$141.60 /

+2.785 (+2.01%)

AAPL Apple
$141.60 /

+2.785 (+2.01%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.